What is it?
What is zeaxanthin?
6Zeaxanthin is a yellow, fat-soluble xanthophyll carotenoid. Along with lutein and meso-zeaxanthin, it contributes to macular pigment in the retina. Supplement labels may describe an isolated ingredient or a multi-nutrient eye formula.
Where the eye-health evidence applies
2AREDS2 enrolled people with intermediate AMD in both eyes, or intermediate AMD in one eye and advanced AMD in the other. Its results concern a complete nutrient formula in that population. They do not establish a benefit from isolated zeaxanthin for people without AMD.
The large cognitive trial was null
10In AREDS2, 3,501 older adults with AMD underwent cognitive testing. Adding lutein and zeaxanthin did not significantly improve cognitive outcomes over a median five years. This is an important counterweight to small positive studies.
What the smaller studies found
5A 12-month trial analyzed 51 older adults taking lutein plus zeaxanthin or placebo. Attention and cognitive flexibility improved, while the reported memory signal was confined to men. Small samples, multiple cognitive outcomes and the combined ingredients limit generalization.
Standalone research has narrow endpoints
11A four-month study included a zeaxanthin-only group and a separate mixed-formula group. Reported visual-processing improvements came from pooled active groups tested for change from baseline; the placebo group had only ten participants. This offers a narrow research signal, not proof of broad standalone cognitive enhancement.
Newer evidence remains combination-specific
12A 2026 trial in 82 teenagers with high screen use and low fruit and vegetable intake tested lutein plus zeaxanthin for six months. It found attention and processing-speed signals, but no benefit on several other tests or self-reported attention and sleep. It does not establish an adult zeaxanthin-only benefit.
Names, aliases and forms
Mechanisms of action
Macular pigment biology
3Zeaxanthin and lutein are concentrated in retinal tissue, where light absorption and antioxidant activity are relevant to eye biology. These mechanisms do not by themselves demonstrate improved memory or productivity after supplementation.
Potential effects and evidence map
Grade C describes limited cognitive evidence: small trials report selected attention or visual-processing improvements, while the large AREDS2 cognitive study was null. Many studies combine zeaxanthin with lutein, so benefits cannot be assigned to zeaxanthin alone. The stronger eye-health evidence concerns a complete formula and a specific AMD population.
Long-term cognitive benefit is unproven. The large AREDS2 trial found no significant cognitive benefit from lutein plus zeaxanthin in older adults with AMD.
A reliable memory benefit from zeaxanthin alone has not been established; the lutein-focused trial synthesis found no significant pooled memory improvement.
A small older-adult trial found selected attention improvements with lutein plus zeaxanthin after repeated use.
Typical dosages and timing
This amount accompanies lutein 10 mg and other nutrients in the complete AREDS2 formula. It is a clinical formula reference, not an established cognitive-enhancement dose or a reason to start an eye formula without the relevant eye assessment.
Twenty healthy adults received one of these two daily doses as synthetic zeaxanthin beadlets for 42 days. The study measured plasma kinetics and tolerability, not cognitive efficacy. The two tested amounts are not a recommended dose range.
Timing & effect horizon
The 12-month value describes the small older-adult lutein/zeaxanthin trial. It does not establish how soon an individual will notice a change or how long a benefit lasts. A dependable cognitive effect horizon for zeaxanthin alone remains unknown.
The five-day value is the effective The time for blood levels to fall by half during the final elimination phase.Source for plasma accumulation in the 20-person beadlet study. It describes how blood levels build with repeated dosing. It is not the terminal elimination half-life, a same-day focus onset, or a duration of noticeable benefit.
Safety, side effects and risk profile
Ordinary oral use has a reassuring safety record, but available trials cannot rule out rare reactions or establish every formulation's long-term safety.
The 20-person absorption study reported that both zeaxanthin doses were well tolerated over six weeks. A small short study cannot exclude rare reactions or guarantee lifelong safety. Persistent symptoms after starting a product warrant stopping it and seeking advice.
Interactions and cautions
A pharmacist can assess a full eye formula alongside medicines and other supplements. Ingredient overlap and interaction concerns depend on the entire composition; evidence about a mixture does not establish a zeaxanthin-specific drug interaction.
Legal and regulatory status
As of 14 October 2026, FDA does not approve dietary supplements for safety or effectiveness before sale. A zeaxanthin product listing therefore is not FDA approval of its cognitive or disease claims. Ingredient, dose and claim rules differ across markets; this U.S. summary is not worldwide authorization.
How it compares
These are related macular carotenoids, not interchangeable ingredient names. Lutein is a different molecule; meso-zeaxanthin is a different stereoisomer. Compare each named amount separately instead of assuming that a total carotenoid number describes the same formula.
Practical buying and quality notes
- The older-adult cognitive trial instructed participants to take the combination tablet daily with a meal. Follow the particular product label; the presence of an oil carrier alone does not prove superior cognitive or eye outcomes.5
- If the label means 5% zeaxanthin by weight, a 100 g pack contains 5 g of active zeaxanthin. The remaining mass is other material. Compare the declared active amount and serving count, not gross powder grams against pure ingredient or capsule prices. This is label arithmetic, not a powder-dosing instruction.7
- Some catalog package-size fields need reconciliation. Check the merchant's selected variant, package weight, concentration and serving label before relying on a unit price. A powder amount and the active zeaxanthin amount are different quantities.7
FAQ
Does zeaxanthin improve focus?
4Small studies report selected attention or visual-processing findings, but the evidence does not establish reliable same-day focus or a standalone cognitive dose. Lutein-focused pooled analyses have not shown significant overall attention, memory or executive-function benefits.
Does a higher amount guarantee better results?
8No. In the plasma study, the higher tested dose increased blood levels but had lower dose-normalized bioavailability. Blood concentration is not a measure of cognitive benefit, and that study did not test a cognitive dose-response relationship.
Can zeaxanthin powder replace an AREDS2 formula?
2No evidence establishes that substitution. Zeaxanthin powder supplies only one component, whereas the AREDS2 formula also contains lutein, vitamins C and E, zinc and copper. Match the complete label to the formula recommended by an eye-care professional.
References
- PubChem Compound Summary for Zeaxanthin. National Center for Biotechnology Information.
- National Eye Institute. AREDS/AREDS2 Clinical Trials: About AREDS and AREDS2.
- National Eye Institute. AREDS/AREDS2 Frequently Asked Questions.
- Li J, Abdel-Aal ESM. Dietary Lutein and Cognitive Function in Adults: A Meta-Analysis of Randomized Controlled Trials. Molecules. 2021;26(19):5794.
- Hammond BR Jr, Miller LS, Bello MO, Lindbergh CA, Mewborn C, Renzi-Hammond LM. Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial. Front Aging Neurosci. 2017;9:254.
- Eisenhauer B, Natoli S, Liew G, Flood VM. Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection. Nutrients. 2017;9(2):120.
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements.
- Hartmann D, Thurmann PA, Spitzer V, Schalch W, Manner B, Cohn W. Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr. 2004;79(3):410-417.
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Statement on the safety of synthetic zeaxanthin as an ingredient in food supplements. EFSA Journal. 2012;10(10):2891.
- Chew EY, Clemons TE, Agron E, et al. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial. JAMA. 2015;314(8):791-801.
- Bovier ER, Renzi LM, Hammond BR. A Double-Blind, Placebo-Controlled Study on the Effects of Lutein and Zeaxanthin on Neural Processing Speed and Efficiency. PLoS One. 2014;9(9):e108178.
- Lopresti AL, Smith SJ. Supplementation with lutein and zeaxanthin increases macular pigment optical density and cognitive performance in healthy teenagers in a randomized, double-blind, placebo-controlled trial. Nutr Res. 2026;152:132-144.